School of Medicine
Showing 41-50 of 134 Results
-
Rachel Keranen
Casual - Non-Exempt, Medicine
Current Role at StanfordExecutive and strategic communications for the Department of Medicine.
-
Arash Keshavarzi
Postdoctoral Scholar, Cardiovascular Medicine
BioArash has a background in molecular biology and chemistry, and earned his PhD in AI-driven drug discovery, where his work led to the identification of three candidate drugs for breast cancer, validated both in vitro and in vivo. Following this, he joined a lab at UCSF for his first postdoctoral position which led to a patent for AI drug discovery applications which led to multiple patents and articles. Throughout his career, Arash has also been involved in multiple ventures. He served as the Chief Scientific Officer at Nucleus Genomics with $17 million seed funding, and co-founded Lumos Bio, a stealth focused on RNA-targeted drug discovery. Currently, Arash is a NIH T32 fellow postdoc in the Ashley Lab and an investment fellow in Mubadala Capital
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine.
In his clinical practice, he treats patients with all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. He also regularly attends on the inpatient oncology service at Stanford Hospital.
With each patient, he is devoted to providing exceptional, humanistic care and has been recognized throughout his career for his humanism. As a medical student, he was named to the national Gold Humanism Honor Society and he received the Reza Gandjei Humanism Award as a medical resident at UCSF.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He also has studied health care utilization and costs for end-of-life care of cancer patients.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. In addition, he is an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers.
